| Name |
Format |
Description |
Link |
| Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a01-eng.pdf |
| Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a01f-fra.pdf |
| Infographic: Summary of RSV vaccine products in late-stage development |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a02a-eng.pdf |
| Infographic: Summary of RSV vaccine products in late-stage development |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a02af-fra.pdf |
| Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreat |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a02-eng.pdf |
| Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreat |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a02f-fra.pdf |
| Large community mumps outbreak in Manitoba, Canada, September 2016–December 2018 |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a03-eng.pdf |
| Large community mumps outbreak in Manitoba, Canada, September 2016–December 2018 |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a03f-fra.pdf |
| Measles surveillance in Canada: 2018 |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a04-eng.pdf |
| Measles surveillance in Canada: 2018 |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a04f-fra.pdf |
| Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010–2016 |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a05-eng.pdf |
| Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010–2016 |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a05f-fra.pdf |
| Motivational interviewing: A powerful tool to address vaccine hesitancy |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a06-eng.pdf |
| Motivational interviewing: A powerful tool to address vaccine hesitancy |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a06f-fra.pdf |
| Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists; Coronavirus disease (COVID-19) |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a07-eng.pdf |
| Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists; Coronavirus disease (COVID-19) |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a07f-fra.pdf |
| CCDR: Volume 46-04 -April 2020: Respiratory syncytial virus (RSV) |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04-eng.pdf |
| CCDR: Volume 46-04 -April 2020: Respiratory syncytial virus (RSV) |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04f-fra.pdf |
| Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/article-1-challenges-developing-vaccine-respiratory-syncytial-virus.html |
| Infographic: Summary of RSV vaccine products in late-stage development |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/article-2a-respiratory-syncytial-virus-vaccine-products.html |
| Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreat |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/article-2-report-canada-readiness-rsv-vaccines.html |
| Large community mumps outbreak in Manitoba, Canada, September 2016–December 2018 |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/article-3-mumps-outbreak-manitoba-canada-2018-2019.html |
| Measles surveillance in Canada: 2018 |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/article-4-report-measles-canada-2018.html |
| Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010–2016 |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/article-5-clinical-risk-factors-drug-resistant-tuberculosis-ontario-canada-2010-2016.html |
| Motivational interviewing: A powerful tool to address vaccine hesitancy |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/article-6-canvax-addressing-vaccine-hesitancy.html |
| Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists; Coronavirus disease (COVID-19) |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/article-7-id-news.html |
| CCDR: Volume 46-04 -April 2020: Respiratory syncytial virus (RSV) |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020.html |
| Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-4-2-avril-2020/article-1-defis-matiere-creation-vaccin-contre-virus-respiratoire-syncytial.html |
| Infographic: Summary of RSV vaccine products in late-stage development |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-4-2-avril-2020/article-2a-produits-vaccinaux-contre-virus-respiratoire-syncytial.html |
| Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreat |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-4-2-avril-2020/article-2-rapport-preparation-canada-vaccins-vrs.html |
| Large community mumps outbreak in Manitoba, Canada, September 2016–December 2018 |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-4-2-avril-2020/article-3-eclosion-oreillons-manitoba-canada-2018-2019.html |
| Measles surveillance in Canada: 2018 |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-4-2-avril-2020/article-4-rapport-rougeole-canada-2018.html |
| Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010–2016 |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-4-2-avril-2020/article-5-facteurs-risque-cliniques-tuberculose-multiresistante-ontario-canada-2010-2016.html |
| Motivational interviewing: A powerful tool to address vaccine hesitancy |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-4-2-avril-2020/article-6-canvax-vaincre-reticence-vaccination.html |
| Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists; Coronavirus disease (COVID-19) |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-4-2-avril-2020/article-7-actualites-maladies-infectieuses.html |
| CCDR: Volume 46-04 -April 2020: Respiratory syncytial virus (RSV) |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-4-2-avril-2020.html |